Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation
Laura Kulik(Northwestern University), Riad Salem(Northwestern University), Mary F. Mulcahy(Northwestern University), Tameem Souman(Northwestern University), Lodewijk van Holsbeeck(Northwestern University), Russell Hunter(West Virginia University), Michaël Abécassis(University of Arizona), Albert A. Nemcek(Northwestern Medicine), Bassel Atassi(Society of Interventional Radiology), Kenneth G. Haines(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology)
Cited by 331
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k